Company Filing History:
1 out of 2,010 
1 out of 1,373 
Years Active: 2015
Title: Thomas Gainer: Innovator in Neuroprotective Compounds
Introduction
Thomas Gainer is an accomplished inventor based in Swampscott, MA (US). He has made significant contributions to the field of neuroprotection through his innovative research and development of EphB3 kinase inhibitor compounds. His work has the potential to impact treatments for conditions such as stroke.
Latest Patents
Thomas Gainer holds a patent for "Inhibiting Eph B-3 kinase," which includes EphB3 kinase inhibitor compounds. These compounds, particularly certain pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine compounds, demonstrate greater potency in inhibiting EphB3 kinase compared to general kinase inhibitors. The pharmaceutical compositions derived from these compounds can serve as neuroprotective agents, providing essential support for neuronal tissue repair following ischemic events.
Career Highlights
Throughout his career, Thomas Gainer has worked with prestigious institutions, including Duke University and Brigham and Women's Hospital, Inc. His research has focused on developing effective treatments that can enhance neuroprotection and facilitate recovery from neurological damage.
Collaborations
Thomas has collaborated with notable colleagues, including Lixin Qiao and Marcie A Glicksman. Their combined expertise has contributed to the advancement of research in neuroprotective therapies.
Conclusion
Thomas Gainer's innovative work in the field of neuroprotection through EphB3 kinase inhibitors showcases his dedication to improving medical treatments for neurological conditions. His contributions are paving the way for future advancements in this critical area of research.